Skip to main content
SpringerLink
Log in

Ovarian Stimulation in Cancer Patient

  • Chapter
Principles and Practice of Controlled Ovarian Stimulation in ART

  • 1244 Accesses

Abstract

Ovarian stimulation in cancer patients is a relatively new and challenging concept. A large number of cancer patients in the reproductive-age group are now expected to survive and lead a normal life. However, various therapies responsible for this markedly improved prognosis can also cause a significant detrimental effect on the reproductive ability. It is important that all young patients diagnosed with cancer are fully informed and offered the option of various fertility preservation strategies. Ovarian stimulation followed by either embryo or mature oocyte cryopreservation is currently the most successful option. Special considerations are required while performing ovarian stimulation in cancer patients. A detailed pretreatment assessment, counseling, and proper selection of ovarian stimulation protocol within the available short time period with minimum side effects are crucial to maximize the success of fertility preservation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Louis SL, Saso S, Ghaem-Maghami S, Abdalla H, Smith RJ. The relationship between infertility treatment and cancer including gynaecological cancers. Obstet Gynaecol. 2013;15(3):177–83.

    Google Scholar 

  2. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilization. Lancet. 1999;354(9190):1586–90.

    Article  CAS  PubMed  Google Scholar 

  3. Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013;99(6):1476–84.

    Article  PubMed  Google Scholar 

  4. Anderson RA, Wallace WH. Fertility preservation in girls and young women. Clin Endocrinol (Oxf). 2011;75(4):409–19.

    Article  Google Scholar 

  5. Koch J, Ledger W. Ovarian stimulation protocols for onco-fertility patients. J Assist Reprod Genet. 2013;30(2):203–6.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83(6):1622–8.

    Article  Google Scholar 

  7. Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99(1):37–43.

    Article  Google Scholar 

  8. American Cancer Society. Cancer facts and figures 2012. American Cancer Society, Atlanta; 2012 (Available at: http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012. (Accessed 06 Aug 2014).

  9. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. editors. SEER cancer statistics review, 1975–2009 (vintage 2009 populations). Bethesda: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2009_pops09/. Accessed 06 Aug 2014.

  10. Rodriguez-Wallberg KA, Oktay K. Options on fertility preservation in female cancer patients. Cancer Treat Rev. 2012;38(5):354–61.

    Article  PubMed  Google Scholar 

  11. Connell S, Patterson C, Newman B. Issues and concerns of young Australian women with breast cancer. Support Care Cancer. 2006;14(5):419–26.

    Article  PubMed  Google Scholar 

  12. Peate M, Meiser B, Hickey M, Friedlander M. The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat. 2009;116(2):215–23.

    Article  PubMed  Google Scholar 

  13. Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall LL, Diller L. Infertility, infertility treatment and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Study cohort. Lancet Oncol. 2013;14(9):873–81.

    Article  PubMed  Google Scholar 

  14. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7(6):535–43.

    Article  CAS  PubMed  Google Scholar 

  15. Das M, Shehata F, Moria A, Holzer H, Son WY, Tulandi T. Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancy. Fertil Steril. 2011;96(1):122–5.

    Article  CAS  PubMed  Google Scholar 

  16. Knopman JM, Noyes N, Talebian S, Krey LC, Grifo JA, Licciardi F. Women with cancer undergoing ART for fertility preservation: a cohort study of their response to exogenous gonadotropins. Fertil Steril. 2009;91(4):1476–8.

    Article  PubMed  Google Scholar 

  17. Robertson AD, Missmer SA, Ginsburg ES. Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy. Fertil Steril. 2011;95(2):588–91.

    Article  PubMed  Google Scholar 

  18. Pal L, Leykin L, Schifren JL, Isaacson KB, Chang YC, Nikruil N, et al. Malignancy may adversely influence the quality and behaviour of oocytes. Hum Reprod. 1998;13(7):1837–40.

    Article  CAS  PubMed  Google Scholar 

  19. Klock SC, Zhang JX, Kazer RR. Fertility preservation for female cancer patients: early clinical experience. Fertil Steril. 2010;94(1):149–55.

    Article  PubMed  Google Scholar 

  20. Friedler S, Koc O, Gidoni Y, Raziel A, Ron-El R. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril. 2012;97(1):125–33.

    Article  PubMed  Google Scholar 

  21. Oktay K, Kim JY, Barad D, Babayev SN. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol. 2010;28(2):240–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Lawrenz B, Fehm T, von Wolff M, Soekler M, Huebner S, Henes J, et al. Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma—evaluation by using antimüllerian hormone and retrieved oocytes. Fertil Steril. 2012;98(1):141–4.

    Article  CAS  PubMed  Google Scholar 

  23. Ebbel E, Katz A, Kao CN, Cedars M. Reproductive aged women with cancer have a lower antral follicle count than expected. Fertil Steril. 2011;96 Suppl 3:S199–200.

    Article  Google Scholar 

  24. Reddy J, Oktay K. Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer. Fertil Steril. 2012;98(6):1363–9.

    Article  CAS  PubMed  Google Scholar 

  25. Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod. 2003;18(1):90–5.

    Article  CAS  PubMed  Google Scholar 

  26. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists’ Collaborative Group. Lancet. 1992;339(8785):71–85.

    Google Scholar 

  27. Rodriguez-Wallberg KA, Oktay K. Fertility preservation in women with breast cancer. Clin Obstet Gynecol. 2010;53(4):753–62.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23(19):4347–53.

    Article  CAS  PubMed  Google Scholar 

  29. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75(2):305–9.

    Article  CAS  PubMed  Google Scholar 

  30. Testart J, Frydman R, Nahoul K, Grenier J, Feinstein MC, Roger M, et al. Steroids and gonadotropins during the last pre-ovulatory phase of the menstrual cycle. Time relationships between plasma hormones levels and luteinizing hormone surge onset. J Steroid Biochem. 1982;17(6):675–82.

    Article  CAS  PubMed  Google Scholar 

  31. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91(10):3885–90.

    Article  CAS  PubMed  Google Scholar 

  32. Anderson RA, Kinniburgh D, Baird DT. Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment. Hum Reprod. 1999;14(10):2665–8.

    Article  CAS  PubMed  Google Scholar 

  33. Cakmak H, Zamah AM, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian hyperstimulation. Fertil Steril. 2013;100(6):1673–80.

    Article  PubMed  Google Scholar 

  34. Baerwald AR, Adams GP, Pierson RA.Characterization of ovarian follicular wave dynamics in women. Biol Reprod. 2003;69(3):1023–31.

    Article  CAS  PubMed  Google Scholar 

  35. McArdle CA, Franklin J, Green L, Hislop JN. Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors. J Endocrinol. 2002;173(1):1–11. Review.

    Article  CAS  PubMed  Google Scholar 

  36. Ata B, Chian RC, Tan SL. Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients. Best Pract Res Clin Obstet Gynaecol. 2010;24(1):101–12.

    Article  PubMed  Google Scholar 

  37. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10(3):251–66.

    Article  PubMed  Google Scholar 

  38. Noyes N, Knopman JM, Melzer K, Fino ME, Friedman B, Westphal LM. Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online. 2011;23(3):323–33.

    Article  CAS  PubMed  Google Scholar 

  39. Yoon TK, Lee DR, Cha SK, Chung HM, Lee WS, Cha KY. Survival rate of human oocytes and pregnancy outcome after vitrification using slush nitrogen in assisted reproductive technologies. Fertil Steril. 2007;88(4):952–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, IVF Centre, Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi, Delhi, India

    Sohani Verma MBBS, MRCOG, FRCOG, FICOG, FIMSA

Authors
  1. Sohani Verma MBBS, MRCOG, FRCOG, FICOG, FIMSA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sohani Verma MBBS, MRCOG, FRCOG, FICOG, FIMSA .

Editor information

Editors and Affiliations

  1. Director, IVF & Reproductive Medicine, Department of Obstetrics and Gynecology, MAX Multispecialty Hospitals, New Delhi, India

    Surveen Ghumman

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer India

About this chapter

Cite this chapter

Verma, S. (2015). Ovarian Stimulation in Cancer Patient. In: Ghumman, S. (eds) Principles and Practice of Controlled Ovarian Stimulation in ART. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1686-5_34

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-1686-5_34

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-1685-8

  • Online ISBN: 978-81-322-1686-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation